Subscribe to RSS
DOI: 10.1055/a-2779-7276
Understanding the Impact of Patent Ductus Arteriosus and Treatment Strategies on Acute Kidney Injury in Preterm Infants
Authors
Funding Information P.M.G. is partially supported by the NIGMS of the NIH under award number U54GM115428. A.M.S. is supported by NIH NHLBI R01HL146818, NIH NHLBI K23HL148394, and NIH NHLBI R01HL164434. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Abstract
Acute kidney injury (AKI) is a clinically significant complication in preterm neonates, leading to increased morbidity, mortality, and risk of long-term kidney dysfunction. Within this vulnerable population, the presence of a hemodynamically significant patent ductus arteriosus (PDA) may further exacerbate AKI risk. The relationship between PDA and AKI is complex, involving both the pathophysiological consequences of altered hemodynamics (e.g., ductal steal) causing renal ischemia and the potential nephrotoxic effects of therapeutic interventions. However, the existing literature provided limited insight into the impact of PDA and its management on AKI in preterm infants, with most studies relying on retrospective designs. There is a notable absence of consensus regarding the comparative effects of conservative, pharmacologic, and surgical PDA management strategies on AKI outcomes. This study directly addresses these knowledge gaps by synthesizing findings from diverse clinical trials, cohort studies, and meta-analyses into a single, comprehensive resource, aiming to inform future research and guide best practices for managing PDA-related AKI in preterm neonates.
Key Points
-
AKI in PDA involves ductal steal and nephrotoxic treatment effects.
-
Early AKI detection in hsPDA requires monitoring and balanced treatment.
-
hsPDA is a major risk factor for AKI in preterm infants.
-
Understanding intervention impact on AKI needs well-designed studies.
Keywords
acute kidney injury - patent ductus arteriosus - preterm infant - catheter closure - PDA treatment‡ These authors contributed equally to this article.
Publication History
Received: 16 October 2025
Accepted: 24 December 2025
Accepted Manuscript online:
31 December 2025
Article published online:
14 January 2026
© 2026. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Wong JH, Selewski DT, Yu S. et al. Severe acute kidney injury following stage 1 norwood palliation: effect on outcomes and risk of severe acute kidney injury at subsequent surgical stages. Pediatr Crit Care Med 2016; 17 (07) 615-623
- 2 Harer MW, Pope CF, Conaway MR, Charlton JR. Follow-up of acute kidney injury in neonates during childhood years (FANCY): a prospective cohort study. Pediatr Nephrol 2017; 32 (06) 1067-1076
- 3 Jetton JG, Boohaker LJ, Sethi SK. et al; Neonatal Kidney Collaborative (NKC). Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health 2017; 1 (03) 184-194
- 4 Gupta S, Gaur BK, Jain R, Singh RR. Incidence, risk factors, and outcomes of acute kidney injury in preterm neonates hospitalized in the neonatology unit, north india: a single-center experience. Saudi J Kidney Dis Transpl 2023; 34 (06) 592-601
- 5 Roy JP, Goldstein SL, Schuh MP. Under-recognition of neonatal acute kidney injury and lack of follow-up. Am J Perinatol 2022; 39 (05) 526-531
- 6 Elmas AT, Tabel Y, Özdemir R. Risk factors and mortality rate in premature babies with acute kidney injury. J Clin Lab Anal 2018; 32 (07) e22441
- 7 Garg PM, South AM, Inder T, Shenberger JS. Hypotension: a modifiable risk factor impacting surgical NEC-associated AKI and brain injury in preterm infants. Pediatr Res 2024; 96 (05) 1125-1126
- 8 Steflik HJ, Selewski DT, Corrigan C, Brinton DL. Acute kidney injury associated with increased costs in the neonatal intensive care unit: analysis of Pediatric Health Information System database. J Perinatol 2025; 45 (01) 94-100
- 9 Koralkar R, Ambalavanan N, Levitan EB, McGwin G, Goldstein S, Askenazi D. Acute kidney injury reduces survival in very low birth weight infants. Pediatr Res 2011; 69 (04) 354-358
- 10 Askenazi DJ, Koralkar R, Hundley HE, Montesanti A, Patil N, Ambalavanan N. Fluid overload and mortality are associated with acute kidney injury in sick near-term/term neonate. Pediatr Nephrol 2013; 28 (04) 661-666
- 11 Greenberg JH, Coca S, Parikh CR. Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review. BMC Nephrol 2014; 15: 184
- 12 Chen CC, Chu CH, Lin YC, Huang CC. Neurodevelopment after neonatal acute kidney injury in very preterm-birth children. Kidney Int Rep 2023; 8 (09) 1784-1791
- 13 Mian AN, Guillet R, Ruck L, Wang H, Schwartz GJ. Acute kidney injury in premature, very low-birth-weight infants. J Pediatr Intensive Care 2016; 5 (02) 69-78
- 14 Lee CC, Chan OW, Lai MY. et al. Incidence and outcomes of acute kidney injury in extremely-low-birth-weight infants. PLoS One 2017; 12 (11) e0187764
- 15 Cataldi L, Leone R, Moretti U. et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed 2005; 90 (06) F514-F519
- 16 Meena J, Kumar J, Kocharlakota JP. et al. Acute kidney injury in neonates: a meta-analysis. Pediatrics 2024; 154 (01) e2023065182
- 17 Chen J, Sun Y, Wang S. et al. The effectiveness of urinary TIMP-2 and IGFBP-7 in predicting acute kidney injury in critically ill neonates. Pediatr Res 2020; 87 (06) 1052-1059
- 18 Garg PP, Shenberger J, South AM, Garg PM. Necrotizing enterocolitis-associated acute kidney injury-transforming the paradigm. Am J Perinatol 2025; 42 (01) 108-112
- 19 Garg PM, Pittman IA, Ansari MAY. et al. Gestational age-specific clinical correlates of acute kidney injury in preterm infants with necrotizing enterocolitis. Pediatr Res 2023; 94 (06) 2016-2025
- 20 Gunasekaran V, Rodriguez RJ, Porcelli P, Jawale N, Shenberger J, Garg PM. Clinical impact of the PDA and its management on outcomes of preterm infants with NEC: A Review. Am J Perinatol 2025
- 21 Faa G, Gerosa C, Fanni D. et al. Marked interindividual variability in renal maturation of preterm infants: lessons from autopsy. J Matern Fetal Neonatal Med 2010; 23 (Suppl. 03) 129-133
- 22 Sutherland MR, Gubhaju L, Moore L. et al. Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 2011; 22 (07) 1365-1374
- 23 Carmody JB, Charlton JR. Short-term gestation, long-term risk: prematurity and chronic kidney disease. Pediatrics 2013; 131 (06) 1168-1179
- 24 Gouyon JB, Guignard JP. Management of acute renal failure in newborns. Pediatr Nephrol 2000; 14 (10–11): 1037-1044
- 25 Hentschel R, Lödige B, Bulla M. Renal insufficiency in the neonatal period. Clin Nephrol 1996; 46 (01) 54-58
- 26 Askenazi DJ, Ambalavanan N, Goldstein SL. Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?. Pediatr Nephrol 2009; 24 (02) 265-274
- 27 Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007; 71 (10) 1028-1035
- 28 Mehta RL, Kellum JA, Shah SV. et al; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11 (02) R31
- 29 Jetton JG, Askenazi DJ. Update on acute kidney injury in the neonate. Curr Opin Pediatr 2012; 24 (02) 191-196
- 30 Zappitelli M, Ambalavanan N, Askenazi DJ. et al. Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop. Pediatr Res 2017; 82 (04) 569-573
- 31 Kellum JA. Diagnostic criteria for acute kidney injury: present and future. Crit Care Clin 2015; 31 (04) 621-632
- 32 Kellum JA, Lameire N. KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17 (01) 204
- 33 Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120 (04) c179-c184
- 34 Harer MW, Charlton JR. Urine or you're out? Perspectives on urinary output thresholds in the neonatal acute kidney injury definition. Clin J Am Soc Nephrol 2022; 17 (07) 939-941
- 35 De Mul A, Parvex P, Héneau A. et al. Urine output monitoring for the diagnosis of early-onset acute kidney injury in very preterm infants. Clin J Am Soc Nephrol 2022; 17 (07) 949-956
- 36 Jetton JG, Boohaker LJ, Sethi SK. et al; Neonatal Kidney Collaborative (NKC). Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health 2017; 1 (03) 184-194
- 37 Sulemanji M, Vakili K. Neonatal renal physiology. Semin Pediatr Surg 2013; 22 (04) 195-198
- 38 Tóth-Heyn P, Drukker A, Guignard JP. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 2000; 14 (03) 227-239
- 39 Cuzzolin L, Fanos V, Pinna B. et al. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006; 21 (07) 931-938
- 40 McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007; 92 (06) F424-F427
- 41 Fink D, El-Khuffash A, McNamara PJ, Nitzan I, Hammerman C. Tale of two patent ductus arteriosus severity scores: similarities and differences. Am J Perinatol 2018; 35 (01) 55-58
- 42 Stritzke A. Renal arterial doppler perfusion pattern with and without ductal steal. J Pediatr 2020; 223: 225-226
- 43 Wong SN, Lo RN, Hui PW. Abnormal renal and splanchnic arterial Doppler pattern in premature babies with symptomatic patent ductus arteriosus. J Ultrasound Med 1990; 9 (03) 125-130
- 44 Bömelburg T, Jorch G. Abnormal blood flow patterns in renal arteries of small preterm infants with patent ductus arteriosus detected by Doppler ultrasonography. Eur J Pediatr 1989; 148 (07) 660-664
- 45 Lemmers PM, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 2008; 121 (01) 142-147
- 46 Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994; 125 (02) 270-277
- 47 Hsu KH, Nguyen J, Dekom S, Ramanathan R, Noori S. Effects of patent ductus arteriosus on organ blood flow in infants born very preterm: a prospective study with serial echocardiography. J Pediatr 2020; 216: 95-100.e2
- 48 Condit PE, Chuck JE, Lasarev MR, Chock VY, Harer MW. Renal tissue oxygenation and development of AKI in preterm neonates born < 32 weeks' gestational age in the first week of age. J Perinatol 2024; 44 (03) 434-438
- 49 Petrova A, Bhatt M, Mehta R. Regional tissue oxygenation in preterm born infants in association with echocardiographically significant patent ductus arteriosus. J Perinatol 2011; 31 (07) 460-464
- 50 van der Laan ME, Roofthooft MT, Fries MW. et al. A hemodynamically significant patent ductus arteriosus does not affect cerebral or renal tissue oxygenation in preterm infants. Neonatology 2016; 110 (02) 141-147
- 51 Gleason CA. Prostaglandins and the developing kidney. Semin Perinatol 1987; 11 (01) 12-21
- 52 Antonucci R, Fanos V. NSAIDs, prostaglandins and the neonatal kidney. J Matern Fetal Neonatal Med 2009; 22 (Suppl. 03) 23-26
- 53 Guignard JP. The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit. Semin Perinatol 2002; 26 (06) 398-405
- 54 Drukker A. The adverse renal effects of prostaglandin-synthesis inhibition in the fetus and the newborn. Paediatr Child Health 2002; 7 (08) 538-543
- 55 Bhatt M, Petrova A, Mehta R. Does treatment of patent ductus arteriosus with cyclooxygenase inhibitors affect neonatal regional tissue oxygenation?. Pediatr Cardiol 2012; 33 (08) 1307-1314
- 56 Dixit M, Doan T, Kirschner R, Dixit N. Significant acute kidney injury due to non-steroidal anti-inflammatory drugs: inpatient setting. Pharmaceuticals (Basel) 2010; 3 (04) 1279-1285
- 57 Hallman M, Treluyer JM, Aikio O, Rozé JC. Early closure mechanisms of the ductus arteriosus in immature infants. Acta Paediatr 2021; 110 (07) 1995-2007
- 58 Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 2020; 1 (01) CD010061
- 59 Herron C, Forbes TJ, Kobayashi D. Renal function after transcatheter piccolo patent ductus arteriosus closure with contrast angiography in extremely premature infants. Am J Cardiol 2022; 181: 113-117
- 60 Lembo C, Méot M, Mellul K. et al. Renal function after ductus arteriosus transcatheter closure with or without angiography in very preterm infants. Acta Paediatr 2024; 113 (05) 955-961
- 61 Xiong P, Chen Q, He Y. Application of single venous approach under echocardiography without angiography in closure of patent ductus arteriosus. J Cardiothorac Surg 2024; 19 (01) 676
- 62 Bagnoli F, Rossetti A, Messina G, Mori A, Casucci M, Tomasini B. Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns. J Matern Fetal Neonatal Med 2013; 26 (04) 423-429
- 63 Balachander B, Mondal N, Bhat V. et al. Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms - a prospective randomized clinical trial. J Matern Fetal Neonatal Med 2020; 33 (09) 1587-1592
- 64 Hammerman C, Shchors I, Jacobson S. et al. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?. Pediatr Res 2008; 64 (03) 291-297
- 65 Sellmer A, Bech BH, Bjerre JV. et al. Urinary neutrophil gelatinase-associated lipocalin in the evaluation of patent ductus arteriosus and AKI in very preterm neonates: a cohort study. BMC Pediatr 2017; 17 (01) 7
- 66 Waldherr S, Fichtner A, Beedgen B. et al. Urinary acute kidney injury biomarkers in very low-birth-weight infants on indomethacin for patent ductus arteriosus. Pediatr Res 2019; 85 (05) 678-686
- 67 Condit PE, Guillet R, Kaluarachchi D. et al. Association of patent ductus arteriosus treatment in extremely low gestational age neonates with two year kidney outcomes: a secondary analysis of the preterm erythropoietin neuroprotection trial (PENUT). BMC Nephrol 2025; 26 (01) 138
- 68 Borysova TP, Obolonska OY. Effect of ibuprofen for hemodynamically significant patent ductus arteriosus closure on the development of acute kidney injury in preterm infants. Med Perspekt 2021; 26 (01) 156-162
- 69 Majed B, Bateman DA, Uy N, Lin F. Patent ductus arteriosus is associated with acute kidney injury in the preterm infant. Pediatr Nephrol 2019; 34 (06) 1129-1139
- 70 Coffman Z, Steflik D, Chowdhury SM, Twombley K, Buckley J. Echocardiographic predictors of acute kidney injury in neonates with a patent ductus arteriosus. J Perinatol 2020; 40 (03) 510-514
- 71 Seo ES, Sung SI, Ahn SY, Chang YS, Park WS. Changes in serum creatinine levels and natural evolution of acute kidney injury with conservative management of hemodynamically significant patent ductus arteriosus in extremely preterm infants at 23-26 weeks of gestation. J Clin Med 2020; 9 (03) 699
- 72 Velazquez DM, Reidy KJ, Sharma M, Kim M, Vega M, Havranek T. The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns. J Matern Fetal Neonatal Med 2019; 32 (19) 3209-3214
- 73 Wildes D, Mullaly R, Costigan C, Awan A, El-Khuffash A, Boyle MA. Employing a haemodynamic score to predict acute kidney injury in infants with patent ductus arteriosus. Acta Paediatr 2025; 114 (07) 1609-1615
- 74 Raknoo T, Janjindamai W, Sitaruno S, Dissaneevate S, Ratanajamit C. Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: a 16-year retrospective cohort study. Pharm Pract (Granada) 2021; 19 (04) 2409
- 75 Srinivasjois RM, Nathan EA, Doherty DA, Patole SK. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates–is postnatal age at start of treatment important?. J Matern Fetal Neonatal Med 2006; 19 (12) 793-799
- 76 Ting JY, McDougal K, De Mello A, Kwan E, Mammen C. Acute kidney injury among preterm infants receiving nonsteroidal anti-inflammatory drugs: a pilot study. Pediatr Neonatol 2023; 64 (03) 313-318
- 77 Constance JE, Reith D, Ward RM. et al. Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. J Perinatol 2017; 37 (10) 1093-1102
- 78 Aygün A, Poryo M, Wagenpfeil G. et al. Birth weight, Apgar scores and gentamicin were associated with acute kidney injuries in VLBW neonates requiring treatment for patent ductus arteriosus. Acta Paediatr 2019; 108 (04) 645-653
- 79 Guillet R, Selewski DT, Griffin R, Rastogi S, Askenazi DJ, D'Angio CT. Neonatal Kidney Collaborative. Relationship of patent ductus arteriosus management with neonatal AKI. J Perinatol 2021; 41 (06) 1441-1447
- 80 Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005; 164 (03) 135-140
- 81 Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev 2020; 2 (02) CD003481
- 82 Mitra S, Florez ID, Tamayo ME. et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 2018; 319 (12) 1221-1238
- 83 Huang X, Wang F, Wang K. Paracetamol versus ibuprofen for the treatment of patent ductus arteriosus in preterm neonates: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2018; 31 (16) 2216-2222
- 84 Mitra S, Scrivens A, Fiander M, Disher T, Weisz DE. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. Cochrane Database Syst Rev 2025; 6 (06) CD013278
- 85 Mitra S, de Boode WP, Weisz DE, Shah PS. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2023; 4 (04) CD013588
- 86 Wildes DM, Dunne E, Mullaly R. et al. A systematic review of the incidence of acute kidney injury in infants with patent ductus arteriosus. Curr Pediatr Rep 2024
- 87 Dias Maia P, Rodrigues KK, Gien J, Turner MJ. Neonatal acute kidney injury during indomethacin therapy: does it predict ductal closure?. J Nephrol 2023; 36 (06) 1591-1597
- 88 El-Khuffash A, James AT, Corcoran JD. et al. A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr 2015; 167 (06) 1354-1361.e2
- 89 Evans RE, Peterson J, Kim JJ, Mahaveer A. How to know when little kidneys are in trouble: a review of current tools for diagnosing AKI in neonates. Front Pediatr 2023; 11: 1270200
- 90 Inotani S, Kashio T, Osakabe Y. et al. Efficacy of urinary [TIMP-2]∙[IGFBP7], L-FABP, and NGAL levels for predicting community-acquired acute kidney injury in Japanese patients: a single-center, prospective cohort study. Clin Exp Nephrol 2025; 29 (07) 928-936
- 91 Xu X, Nie S, Xu H. et al. Detecting neonatal AKI by serum cystatin C. J Am Soc Nephrol 2023; 34 (07) 1253-1263
- 92 Akkoc G, Duzova A, Korkmaz A, Oguz B, Yigit S, Yurdakok M. Long-term follow-up of patients after acute kidney injury in the neonatal period: abnormal ambulatory blood pressure findings. BMC Nephrol 2022; 23 (01) 116
- 93 Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 2012; 82 (05) 516-524
- 94 Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81 (05) 442-448
- 95 Mitra S, Scrivens A, von Kursell AM, Disher T. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. Cochrane Database Syst Rev 2020; 12 (12) CD013278
